A

AIM ImmunoTech Inc. (AIM)

ASE – Real vaqt narxi. Valyuta: USD

0.28

+0.02 (7.83%)

Yopilishda: Aug 5, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

A

AIM ImmunoTech Inc. (AIM)

ASE – Real vaqt narxi. Valyuta: USD

0.28

+0.02 (7.83%)

Yopilishda: Aug 5, 2026, 4:00 PM EDT

03.08.2026

AIM ImmunoTech Ahead of Schedule on ‘Last Dose' DURIPANC Critical Clinical Inflection Point

Milestone Advances Ampligen® Toward Key Clinical Benefit Readout in December 2026 and Overall Survival Analysis in Mid-2027 Milestone Advances Ampligen® Toward Key Clinical Benefit Readout in December 2026 and Overall Survival Analysis in Mid-2027

Videolar

No Data

There is no data to display

Press-relizlar

03.08.2026

AIM ImmunoTech Ahead of Schedule on ‘Last Dose' DURIPANC Critical Clinical Inflection Point

Milestone Advances Ampligen® Toward Key Clinical Benefit Readout in December 2026 and Overall Survival Analysis in Mid-2027 Milestone Advances Ampligen® Toward Key Clinical Benefit Readout in December 2026 and Overall Survival Analysis in Mid-2027

Search stocks

AIM ImmunoTech Inc. (AIM)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Ahead of Schedule on ‘Last Dose' DURIPANC Critical Clinical Inflection Point

Videolar

No Data

Press-relizlar

AIM ImmunoTech Ahead of Schedule on ‘Last Dose' DURIPANC Critical Clinical Inflection Point